Monoclonal antibody
Type ?
Source Human
Target angiopoietin 3
Clinical data
ATC code none
CAS Number 1446419-85-7
ChemSpider none
Chemical and physical data
Formula C6480H9992N1716O2042S46
Molar mass 146.1 kg/mol

Evinacumab is a monoclonal antibody designed for the treatment of dyslipidemia.[1]

This drug was developed by Regeneron Pharmaceuticals, Inc.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Evinacumab, American Medical Association.
This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.